<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://blog.athleticsmd.org/compounded-vs-brand-glp-1-medicines-what-fda-has-said-as-of-october-2026</loc><news:news><news:publication><news:name>AthleticsMD Clinical Desk</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-09T10:00:25.072Z</news:publication_date><news:title>Compounded vs brand GLP-1 medicines: what FDA has said as of October 2026</news:title></news:news></url><url><loc>https://blog.athleticsmd.org/glp-1-drugs-for-obstructive-sleep-apnea-a-new-review-positions-them-as-an-adjunc</loc><news:news><news:publication><news:name>AthleticsMD Clinical Desk</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-08T10:30:40.299Z</news:publication_date><news:title>GLP-1 drugs for obstructive sleep apnea: a new review positions them as an adjunct to CPAP</news:title></news:news></url><url><loc>https://blog.athleticsmd.org/acl-prehabilitation-what-a-36-study-systematic-review-found-and-what-it-cannot-s</loc><news:news><news:publication><news:name>AthleticsMD Clinical Desk</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-08T10:00:40.275Z</news:publication_date><news:title>ACL prehabilitation: what a 36-study systematic review found, and what it cannot show</news:title></news:news></url><url><loc>https://blog.athleticsmd.org/colorectal-cancer-at-21-and-younger-most-of-84-patients-had-stage-iii-or-iv-dise</loc><news:news><news:publication><news:name>AthleticsMD Clinical Desk</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-08T01:00:40.101Z</news:publication_date><news:title>Colorectal cancer at 21 and younger: most of 84 patients had Stage III or IV disease</news:title></news:news></url></urlset>